News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Singer Nicholas Jason
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
SC 13G
| Singer Nicholas Jason reports a 5.2% stake in Comera Life Sciences Holdings, Inc. |
| 07/26/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/20/2022 |
SC 13D
| Singer Nicholas Jason reports a 7.7% stake in Eterna Therapeutics Inc. |
| 12/06/2022 |
4
| Singer Nicholas Jason (Director) has filed a Form 4 on Eterna Therapeutics Inc.|
Txns:
| Bought 70,822 shares
@ $3.28, valued at
$232.3k
Bought 212,464 shares
@ $3.28, valued at
$696.9k
Bought 141,644 warrants
@ $0.125, valued at
$17.7k
Bought 424,928 warrants
@ $0.125, valued at
$53.1k
|
|
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
SC 13G/A
| Singer Nicholas Jason reports a 4% stake in Brooklyn ImmunoTherapeutics, Inc. |
| 04/30/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/17/2020 |
3
| Singer Nicholas Jason (CEO) has filed a Form 3 on OTR Acquisition Corp. |
|
|